Form 144 Zai Lab Ltd Filed by: Chen Yajing

Go back to Form 144 Zai Lab Ltd Filed by: Chen Yajing

Zai Lab (ZLAB) PT Raised to $75 at Leerink Partners

June 30, 2025 1:07 PM UTC

Leerink Partners analyst Jonathan Chang raised the price target on Zai Lab (NASDAQ: ZLAB) to $75.00 (from $73.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: ZLAB partner AMGN (MP, Risinger) announced today that the Phase III FORTITUDE-101 study evaluating bemarituzumab in combination with chemotherapy in 1L FGFR2b+... More